Lancellotti P, Oury C., Recent advances in cardiovascular medicine: from molecular mechanisms to precision care. Acta Cardiol. 2025;80(9):949–953. doi:10.1080/00015385.2025.2579430.
Saldarriaga C, Rivera-Toquica A, Echeverry-Navarrete EJ, et al.Impact of sex on clinical and laboratory parameters in patients with heart failure: insights from the Colombian Heart Failure Registry (RECOLFACA). Acta Cardiol. 2024;79(8):878–885. doi:10.1080/00015385.2024.2391133.
Jiang Y, Zhang L, Liu Z, et al.The value of handheld ultrasound in point-of-care or at home EF prediction. Acta Cardiol. 2025;80(9):979–985. doi:10.1080/00015385.2025.2490382.
Sikandar U, Bonnesen K, Heide-Jørgensen U, et al.Predicting heart failure mortality using the Danish Comorbidity Index for Acute Myocardial Infarction (DANCAMI). Acta Cardiol. 2025;80(4):342–350. doi:10.1080/00015385.2025.2452131.
Seydel GS, Gunturk I, Akkaya H, et al.The relationship between the new inflammatory markers and disease severity in patients with acute coronary syndrome. Acta Cardiol. 2024;79(7):778–786. doi:10.1080/00015385.2024.2403933.
Shu Y, Lyu SQ, Tan J, et al.Sex differences in patients with atrial fibrillation and acute coronary syndrome or undergoing PCI: a real-world study. Acta Cardiol. 2024;79(10):1119–1132. doi:10.1080/00015385.2024.2432693.
Vallée A., Digital twins for cardiovascular diseases: towards personalised and sustainable care. Acta Cardiol. 2025;80(9):1055–1062. doi:10.1080/00015385.2025.2569027.
Akter S, Choubey M, Rahman MM, et al.Exploring the significance of gut microbiota in cardiovascular health. Acta Cardiol. 2025;28:1–13. doi:10.1080/00015385.2025.2576444.
Bu Z, Bai S, Yang C, et al.Application of an interpretable machine learning method to predict the risk of death during hospitalization in patients with acute myocardial infarction combined with diabetes mellitus. Acta Cardiol. 2025;80(4):358–375. doi:10.1080/00015385.2025.2481662.
Esmaely F, Moradnejad P, Boudagh S, et al.Radiomics and machine learning for predicting valve vegetation in infective endocarditis: a comparative analysis of mitral and aortic valves using TEE imaging. Acta Cardiol. 2025;80(6):575–592. doi:10.1080/00015385.2025.2500887.
Yamasan BE, Korkmaz S., Unveiling miRNA biomarkers for hypertrophic cardiomyopathy through integrated bioinformatics and machine learning analysis. Acta Cardiol. 2025;24:1–14. doi:10.1080/00015385.2025.2577015.
Sarihan A, Kalçık M, Yetim M., The role of volume status and rhythm dynamics in interpreting pulmonary artery pulsatility index in atrial fibrillation and heart failure. Acta Cardiol. 2025;11:1–3. doi:10.1080/00015385.2025.2558381.
Ozaki Y, Uemura Y, Kondo T, et al.Clinical impact of pulmonary artery pulsatility index in patients with atrial fibrillation and heart failure. Acta Cardiol. 2025;80(6):614–622. doi:10.1080/00015385.2025.2510705.
Wang Z, Fang J, Hong H., Evaluation the Value of H2FPEF Score and HFA-PEFF Step E Score in the Diagnosis of Heart Failure with Preserved Ejection Fraction. Acta Cardiol. 2023;15:1–6.
Afshani MR, Torfi E, Akiash N, et al.Effect of empagliflozin on left ventricular volumes in type 2 diabetes or prediabetes heart failure patients with reduced ejection fraction. Acta Cardiol. 2024;79(4):419–425. doi:10.1080/00015385.2023.2240130.
Zhao X, Hu N, Wang L, et al.Vericiguat versus sacubitril/valsartan for the treatment of heart failure with reduced ejection fraction in China: a cost-utility analysis. Acta Cardiol. 2025;80(3):283–291. doi:10.1080/00015385.2025.2484848.
Iacoviello M, Marini M, Gori M, et al.DAPA-HF applicability: the point of view of a cardiology setting. Acta Cardiol. 2023 2023;78(7):840–845. doi:10.1080/00015385.2023.2243130.
Moreno-Rondón L, Ortega-Armas ME, Coronel A, et al.Characteristics, treatment and prognosis of patients with chronic heart failure according to ejection fraction. Results of an Ecuadorian registry. Acta Cardiol. 2024;79(8):942–952. doi:10.1080/00015385.2024.2392335.
Marazia S, Chiariello G, Leonardo A, et al.Multiparametric evaluation of the effects of dapagliflozin in patients with heart failure and reduced ejection fraction. Acta Cardiol. 2025;28:1–6. doi:10.1080/00015385.2025.2569024.
Meekers E, Arcidiacono Z, Baptist R, et al.Optimisation of heart failure management: insights into GDMT and loop diuretic utilisation in a specialised heart failure clinic. Acta Cardiol. 2025;5:1–8. doi:10.1080/00015385.2025.2577014.
Sengupta SP, Okwose NC, MacGowan GA, et al.Home-based physical activity intervention (Active-at-Home-HF) improves left atrial function, exercise duration and quality of life in heart failure with preserved ejection fraction. Acta Cardiol. 2025;4:1–8. doi:10.1080/00015385.2025.2576440.
Çelik MC, Şahin MM, Kalçık M., Questioning the predictive value of dapagliflozin in the No-reflow phenomenon of acute coronary syndromes. Acta Cardiol. 2025;24:1–2. doi:10.1080/00015385.2025.2576456.
Quisi A, Nacar Quisi NS, Alıcı G, et al.Effect of dapagliflozin on the no-reflow phenomenon in patients with acute myocardial infarction and type II diabetes mellitus. Acta Cardiol. 2025;80(4):394–402. doi:10.1080/00015385.2025.2500892.
Parisotto G, Sant’Anna Junior M, Papathanasiou J, et al.Functional determinants and perceived barriers to cardiac rehabilitation as predictors of short-term hospital readmission in acute coronary syndrome: an observational longitudinal cohort study. Acta Cardiol. 2025;28:1–10. doi:10.1080/00015385.2025.2576437.
Polat F, Tüner H, Çakmak ÇB, et al.Impact of cardiac rehabilitation on adherence to secondary prevention measures across STEMI, NSTEMI, and unstable angina pectoris subgroups: a randomized controlled trial in high-risk patients. Acta Cardiol. 2025;28:1–21. doi:10.1080/00015385.2025.2576433.
Yang H, Wang Z, Yang L, et al.Spatiotemporal patterns of the atrial fibrillation/flutter burden due to environmental, behavioral, and metabolic risk factors, 1990–2021: results from the GBD 2021. Acta Cardiol. 2025;5:1–13. doi:10.1080/00015385.2025.2578031.
Kwok CS, Will M, Borovac JA, et al.Hospitalisations during the 30-day period preceding admissions with cardiac arrest. Acta Cardiol. 2025;6:1–9. doi:10.1080/00015385.2025.2577557.
Samuels A, Badeghiesh A, Baghlaf H, et al.Maternal, delivery and neonatal outcomes in women with peripartum cardiomyopathy. A study of a population database. Acta Cardiol. 2025;4:1–9. doi:10.1080/00015385.2025.2581922.
Coskun C, Cetinkaya B., Evaluating the accuracy and readability of ChatGPT-4 responses about cardiac rehabilitation for heart failure patients. Acta Cardiol. 2025;24:1–6. doi:10.1080/00015385.2025.2576451.
Mok D, Vo T, Jacombs E, et al.The overlooked right atrial appendage. Acta Cardiol. 2025;24:1–2. doi:10.1080/00015385.2025.2538407.
Dong L, He Y, He J., Multimodal imaging diagnosis of a case of coronary sinus orifice atresia with multi-path venous collateral. Acta Cardiol. 2025;5:1. doi:10.1080/00015385.2025.2554394.
Murray C, Cronin M, Devitt P, et al.Unrepaired hemitruncus arteriosus in adulthood. Acta Cardiol. 2025;7:1–2. doi:10.1080/00015385.2025.2569026.
Raczka N, Doyen B., Infiltrative cardiac and peri-aortic mass. Acta Cardiol. 2025;28:1.
